VEGFA and myocardial infarction: Furthermore, adeno-associated virus (AAV)-mediated administration of VEGF-B167 preserved cardiac contractility in rats after experimental myocardial infarction (Zentilin et al, 2010), as well as in dogs subjected to tachypacing-induced dilated cardiomyopathy (Pepe et al, 2010).